impact factor
logo
 

One year in review

 

One year in review 2018: novelties in the treatment of rheumatoid arthritis


1, 2, 3, 4, 5, 6

 

  1. Rheumatology Unit, Department of Clinical Sciences, University of Ferrara, Italy. alessandra.bortoluzzi@unife.it
  2. Rheumatology Unit, Department of Clinical Sciences, University of Ferrara, Italy.
  3. Division of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy.
  4. Rheumatology Unit, Department of Clinical Sciences, University of Ferrara, Italy.
  5. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  6. Rheumatology Unit, Department of Clinical Sciences, University of Ferrara, Italy.

CER11320
2018 Vol.36, N°3
PI 0347, PF 0361
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 29798748 [PubMed]

Received: 11/04/2018
Accepted : 11/04/2018
In Press: 17/05/2018
Published: 17/05/2018

Abstract

The current approach to treatment of rheumatoid arthritis (RA) includes early and aggressive intervention aiming to reach early and persistent low disease activity and remission. New drugs have improved the therapeutic armamentarium of rheumatologists, providing new options for patients. Beyond these innovations, new evidence has improved the safety of therapies and provided tools for the optimisation of long-term management of RA. This paper reviews the most relevant studies published over the last year in the field of treatment of RA.

Rheumatology Article